Clinical Trial: A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07639021) titled 'A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity' on June 05.

Brief Summary: The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.

Study Start Date: June 09

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: NNC0662-0419

NNC0662-0419 will be administered subcutaneously.

DRUG: Semaglutide

Semaglutide will be administered subcutaneously.

DRUG: NNC0662-0419 Placebo

Placebo matched to NNC0662-0419 will be administered subcutaneously.

DRUG: Semaglutide placebo

Placebo matched to s...